Top Markets
Coin of the day
Solvonis Therapeutics plc Solvonis Therapeutics plc

Solvonis Therapeutics plc

SVNS
Ранг среди акций #40469
Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January... Graft Polymer (UK) Plc, set to become Solvonis Therapeutics plc in January 2025, is dedicated to the research and development of advanced polymer modification technologies and techniques. Its operations span the United Kingdom, Slovenia, and across Europe. The company offers a diverse portfolio of specialized products: GRAFTABOND: A line of graft/block copolymers designed to robustly combine various polymers with materials such as fiberglass, carbon fiber, mineral and natural fillers, and even mixed polymer waste. GRAFTALEN: These are reactive solid super-concentrates engineered to enhance polyolefin rheology, boost e-modulus, act as chain extenders for PET/PBT, and serve as AOX masterbatches. GRAFTAPOR: Comprising porous polymer-carriers, this line is specifically developed for applications involving liquid chemicals. GRAFTAMID: This series includes high-temperature elastomers, based on nanostructured polyolefin-polyamide alloys. They function as advanced hardening modifiers within polyamide compounds or as standalone components in hot melt adhesive formulations. GRAFTAKIT: Offering reactive liquid or solid super-concentrates embedded in polymeric porous media, GRAFTAKIT is used to optimize reaction extrusion and the modification of compounds. GRAFTALLOY: A range of polymer-polymer nano-alloys crafted to significantly improve abrasion and temperature resistance, boost impact strength, and reduce friction. GRAFTASYNT: This line encompasses synthetic products, notably including halogen-free flame retardants. GRAFTAMER: An innovative smart polymer characterized by thermo-reversible crosslinking, self-hardening, self-healing properties, and shape memory capabilities. The company was founded in 2017 and maintains its headquarters in London, United Kingdom.
Цена акции
$0.00204105
Рыночная капитализация
$138.92K
Изменение (1 день)
5.63%
Изменение (1 год)
-60.44%
Страна
GB
Торговля Solvonis Therapeutics plc (SVNS)

Категория

цена SVNS с рыночной капитализацией B
Solvonis Therapeutics plc Solvonis Therapeutics plc
SVNS
$0.00204105
Рыночная капитализация Solvonis Therapeutics plc(SVNS)
Рыночная капитализация: $138.92K
По состоянию на August 2026 рыночная капитализация Solvonis Therapeutics plc составляет $138.92K. Согласно нашим данным, Solvonis Therapeutics plc занимает 40469th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Solvonis Therapeutics plc с 2022 по 2026
SVNS по сравнению с пятеркой самых популярных stocks
Цена за SVNS Актив Б Рыночная капитализация B результаты
Solvonis Therapeutics plc Solvonis Therapeutics plc
$80,358.71 $138.92K
$5.470T +3,937,121,289.65%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$65,630.42 $138.92K
$4.467T +3,215,518,705.67%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$61,330.28 $138.92K
$4.174T +3,004,836,235.16%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$54,361.71 $138.92K
$3.700T +2,663,415,733.27%
Solvonis Therapeutics plc Solvonis Therapeutics plc
$41,936.14 $138.92K
$2.854T +2,054,633,061.29%